Paper26558489
An overview of molecular fingerprint similarity search in virtual screening.
Muegge I and 1 other. Expert Opin Drug Discov, 2016. Cited by 158 papers, by iCite.
Cite this record
ConductScience Library. An overview of molecular fingerprint similarity search in virtual screening. Papers, record 26558489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26558489
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Computer Simulation | Major topic |
| Computer-Aided Design | Major topic |
| Drug Design | Major topic |
| Chemistry, Pharmaceutical | |
| Humans | |
| Models, Molecular | |
| Molecular Targeted Therapy | |
| Pharmaceutical Preparations | |
| Structure-Activity Relationship |
Source PubMed
Cited by98
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964728 | PolyBench: A Reproducible Open Benchmark Platform for Repeat-Unit-Based Polymer Property Prediction. | Polym Sci Technol | 2026 | https://conductscience.org/library/papers/42964728 | PubMed |
| 42929586 | scikit-fingerprints: A Python Library for Scikit-Learn-Compatible Molecular Fingerprints and Chemoinformatics. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/42929586 | PubMed |
| 42929555 | Validation Strategy Dominates Model Choice in Chronological QSAR Evaluation. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/42929555 | PubMed |
| 42917444 | Toward High-Throughput Virtual Screening via Quasi-Adiabatic Quantum Geometry Optimization Workflow. | J Chem Theory Comput | 2026 | https://conductscience.org/library/papers/42917444 | PubMed |
| 42799473 | Rational High-Throughput Screening of Cocrystals: An Explainable Deep Learning Framework Based on Morgan Fingerprints and Cross-Attention. | ACS Phys Chem Au | 2026 | https://conductscience.org/library/papers/42799473 | PubMed |
| 42598383 | Machine Learning-Assisted Discovery of Chiral Azobenzene Dopants for Liquid Crystals. | ACS Omega | 2026 | https://conductscience.org/library/papers/42598383 | PubMed |
| 42515695 | In Silico Selection of GAT-1 Inhibitors. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515695 | PubMed |
| 42450187 | The Pharmacokinetic Properties of Veterinary Antiparasitic Drugs in the Context of Human Pregnancy-An In Silico Study. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450187 | PubMed |
| 42450047 | Integrated Screening Cascades for Ion-Channel Drug Discovery: Linking Structure, Electrophysiology, Safety Pharmacology, and Human-Relevant Models. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450047 | PubMed |
| 42328973 | Machine Learning-Based Models to Predict Drug-Induced Liver Injury (DILI) to Assist Medicinal Chemistry. | J Med Chem | 2026 | https://conductscience.org/library/papers/42328973 | PubMed |
| 42297903 | Target-driven machine learning-enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitors. | Commun Chem | 2026 | https://conductscience.org/library/papers/42297903 | PubMed |
| 42296331 | DrugDL: dual-modal deep learning framework for multi-property drug prediction and targeted therapy discovery. | Bioinformatics | 2026 | https://conductscience.org/library/papers/42296331 | PubMed |
| 42218713 | Quantum computing applications in drug discovery. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42218713 | PubMed |
| 42194030 | Targeting Selectivity: Improving Golgi α-Mannosidase II (GMII) Inhibitors Through In Silico Studies. | Biomolecules | 2026 | https://conductscience.org/library/papers/42194030 | PubMed |
| 42182465 | A chemoinformatics-guided platform for efficient discovery of RNA-binding small molecules: Proof-of-concept for myotonic dystrophy type 1. | bioRxiv | 2026 | https://conductscience.org/library/papers/42182465 | PubMed |
| 41984199 | Explainable Machine Learning for Efficient Cocrystal Prediction: Leveraging Morgan Fingerprints to Decode Local Structure-Cocrystal Formation Relationships. | J Phys Chem A | 2026 | https://conductscience.org/library/papers/41984199 | PubMed |
| 41550147 | Natural product databases for drug discovery: Features and applications. | Pharm Sci Adv | 2024 | https://conductscience.org/library/papers/41550147 | PubMed |
| 41291006 | MoleculeFormer is a GCN-transformer architecture for molecular property prediction. | Commun Biol | 2025 | https://conductscience.org/library/papers/41291006 | PubMed |
| 41155614 | Interactions of Linalool and Linalyl Acetate with Selected Dog Cytochrome P450 (CYP) Proteins Identified by In Silico Drug Discovery Followed by Molecular Docking Analysis. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155614 | PubMed |
| 40833278 | A Benchmark Set of Bioactive Molecules for Diversity Analysis of Compound Libraries and Combinatorial Chemical Spaces. | J Chem Inf Model | 2025 | https://conductscience.org/library/papers/40833278 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26558489
GET https://conductscience.org/api/papers/v1/26558489/cited_by?page=2